Response to "On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021"

Affiliations

¹ Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Electronic address: Cogswell.petrice@mayo.edu.
² Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
³ Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

Free article

Comment

Petrice M Cogswell et al. Neuroimage. 2022.

Free article

. 2022 May 1:251:118992.

doi: 10.1016/j.neuroimage.2022.118992. Epub 2022 Feb 15.

¹ Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Electronic address: Cogswell.petrice@mayo.edu.
² Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
³ Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

No abstract available

Comment on

Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM, Wiste HJ, Senjem ML, Gunter JL, Weigand SD, Schwarz CG, Arani A, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Kantarci K, Vemuri P, Boeve BF, Mielke MM, Petersen RC, Jack CR Jr. Cogswell PM, et al. Neuroimage. 2021 Jan 1;224:117433. doi: 10.1016/j.neuroimage.2020.117433. Epub 2020 Oct 6. Neuroimage. 2021. PMID: 33035667 Free PMC article.
On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021.
Risk BB, Qiu D. Risk BB, et al. Neuroimage. 2021 Dec 15;245:118646. doi: 10.1016/j.neuroimage.2021.118646. Epub 2021 Oct 11. Neuroimage. 2021. PMID: 34648959 No abstract available.